| http://www.w3.org/ns/prov#value | - ving operational efficiencies and cost reductions, changes in reimbursement for home and daily hemodialysis, changes in the regulatory environment, changes in the historical purchasing patterns and preferences of our customers, including DaVita Inc. and Fresenius, and certain other factors that may affect future operating results and which are detailed in NxStage's filings with the Securities and
|
